73 related articles for article (PubMed ID: 8166714)
1. Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human plasma and culture media of Hep G2 cells.
Koyama T; Koike Y; Toyota S; Miyagi F; Suzuki N; Aoki N
Biochem Biophys Res Commun; 1994 Apr; 200(1):417-22. PubMed ID: 8166714
[TBL] [Abstract][Full Text] [Related]
2. Purification of human alpha 2-antiplasmin with chicken IgY specific to its carboxy-terminal peptide.
Lee SC; Lee KN; Schwartzott DG; Jackson KW; Tae WC; McKee PA
Prep Biochem Biotechnol; 1997 Nov; 27(4):227-37. PubMed ID: 9413556
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.
Miura O; Hirosawa S; Kato A; Aoki N
J Clin Invest; 1989 May; 83(5):1598-604. PubMed ID: 2496145
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and secretion of the fibrinolytic components, including alpha 2-antiplasmin, by a human hepatoma cell line.
Fair DS; Plow EF
J Lab Clin Med; 1983 Mar; 101(3):372-84. PubMed ID: 6186756
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of pro alpha 2-plasmin inhibitor.
Sumi Y; Ichikawa Y; Nakamura Y; Miura O; Aoki N
J Biochem; 1989 Oct; 106(4):703-7. PubMed ID: 2606916
[TBL] [Abstract][Full Text] [Related]
7. Purification of human alpha 2-plasmin inhibitor using monoclonal antibody column chromatography.
Sumi Y; Koike Y; Ichikawa Y; Aoki N
J Biochem; 1989 Aug; 106(2):192-3. PubMed ID: 2808315
[TBL] [Abstract][Full Text] [Related]
8. Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma.
Bangert K; Johnsen AH; Christensen U; Thorsen S
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):623-5. PubMed ID: 8484741
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.
Tamaki T; Aoki N
J Biol Chem; 1982 Dec; 257(24):14767-72. PubMed ID: 6129243
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human C6 promoter: requirement of the CCAAT enhancer binding protein binding site for C6 gene promoter activity.
González S; López-Larrea C
J Immunol; 1996 Sep; 157(6):2282-90. PubMed ID: 8805625
[TBL] [Abstract][Full Text] [Related]
11. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
[TBL] [Abstract][Full Text] [Related]
12. Secretion of alpha 2-plasmin inhibitor is impaired by amino acid deletion in a small region of the molecule.
Toyota S; Hirosawa S; Aoki N
J Biochem; 1994 Feb; 115(2):293-7. PubMed ID: 7911462
[TBL] [Abstract][Full Text] [Related]
13. Differential processing and secretion of the melanoma-associated ME20 antigen.
Maresh GA; Wang WC; Beam KS; Malacko AR; Hellström I; Hellström KE; Marquardt H
Arch Biochem Biophys; 1994 May; 311(1):95-102. PubMed ID: 8185325
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293.
Cappiello MG; Wu Z; Scott BB; McGeehan GM; Harrison RK
Protein Expr Purif; 2004 Sep; 37(1):53-60. PubMed ID: 15294281
[TBL] [Abstract][Full Text] [Related]
15. Purification of human alpha 2-plasmin inhibitor by a one-step immunoaffinity chromatography procedure.
Koyama T; Koike Y; Sugahara Y; Aoki N
Thromb Res; 1992 May; 66(4):451-4. PubMed ID: 1384162
[No Abstract] [Full Text] [Related]
16. Maturation of secreted meprin alpha during biosynthesis: role of the furin site and identification of the COOH-terminal amino acids of the mouse kidney metalloprotease subunit.
Tang J; Bond JS
Arch Biochem Biophys; 1998 Jan; 349(1):192-200. PubMed ID: 9439598
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor.
Mimuro J; Koike Y; Sumi Y; Aoki N
Blood; 1987 Feb; 69(2):446-53. PubMed ID: 2948579
[TBL] [Abstract][Full Text] [Related]
18. Immunoaffinity purification and characterization of lipoprotein-associated coagulation inhibitors from Hep G2 hepatoma, Chang liver, and SK hepatoma cells. A comparative study.
Wun TC; Huang MD; Kretzmer KK; Palmier MO; Day KC; Bulock JW; Fok KF; Broze GJ
J Biol Chem; 1990 Sep; 265(27):16096-101. PubMed ID: 2168880
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines.
Saito H; Goodnough LT; Knowles BB; Aden DP
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5684-7. PubMed ID: 6291058
[TBL] [Abstract][Full Text] [Related]
20. Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.
Kimura S; Aoki N
J Biol Chem; 1986 Nov; 261(33):15591-5. PubMed ID: 2877981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
